Stock-Based Compensation (Details) (USD $) | 12 Months Ended |
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
| Rate | Rate | Rate |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Share-based compensation, number of shares authorized | 10,000,000 | ' | ' |
Share-based compensation, number of shares available for grant | 329,887 | ' | ' |
Deferred compensation arrangement with individual, nonemployee directors, vesting period | 'five | ' | ' |
Deferred compensation arrangement with individual, nonemployee director, service period, former plan | 'six | ' | ' |
Salaries, Wages and Officers' Compensation [Abstract] | ' | ' | ' |
Compensation expense, all share-based payment plans | $1,411 | $1,508 | $1,349 |
Income tax benefit | 348 | 383 | 329 |
Employee Stock Purchase Plan [Abstract] | ' | ' | ' |
Shares purchased during the year | 118,444 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Volatility rate | 11.30% | 11.70% | 11.90% |
Risk-free interest rate | 2.10% | 1.60% | 2.90% |
Expected dividend yield | 1.50% | 1.50% | 1.50% |
Expected life of awards (years) | '9 years 4 months 24 days | '9 years 1 month 6 days | '8 years 10 months 24 days |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' |
Outstanding, beginning balance | 761,254 | ' | ' |
Granted, Stock Options | 198,500 | ' | ' |
Exercised | -297,508 | ' | ' |
Forfeited | 0 | ' | ' |
Outstanding, ending balance | 662,246 | 761,254 | ' |
Exercisable, ending balance | 342,146 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Granted, weighted average exercise price | $23.20 | ' | ' |
Exercised, weighted average exercise price | $7.47 | ' | ' |
Forfeited, weighted average exercise price | $0 | ' | ' |
Outstanding, weighted average exercise price, ending balance | ' | $11.38 | ' |
Exercisable, weighted average remaining contractual life (years) | '3 years 8 months 9 days | ' | ' |
Outstanding, unrecognized compensation cost | 867 | ' | ' |
Outstanding, aggregate intrinsic value | 4,784 | ' | ' |
Exercisable, aggregate intrinisic value | 3,724 | ' | ' |
Number outstanding | 662,246 | ' | ' |
Weighted average remaining contractual life (years) | '5 years 11 months 1 day | ' | ' |
Outstanding options, weighted average exercise price | $16.68 | ' | ' |
Number exercisable | 342,146 | ' | ' |
Exercisable options, weighted average exercise price | $13.02 | ' | ' |
Employee Stock Purchase Plan [Member] | ' | ' | ' |
Employee Stock Purchase Plan [Abstract] | ' | ' | ' |
Employee stock purchase, discount from market price, purchase date | 15.00% | ' | ' |
Number of employees participating | 1,500 | 1,157 | 1,272 |
Shares purchased during the year | 118,444 | 136,947 | 150,253 |
Weighted-average per share purchase price paid | $20.01 | $17.20 | $15.46 |
Cumulative shares purchased since 1982 | 8,636,226 | 8,517,782 | 8,380,835 |
Employee Stock Purchase Plan [Member] | ' | ' | ' |
Salaries, Wages and Officers' Compensation [Abstract] | ' | ' | ' |
Compensation expense, all share-based payment plans | 417 | 415 | 410 |
Employee Stock Purchase Plan [Abstract] | ' | ' | ' |
Employee stock purchase plan, service period | '1 year | ' | ' |
Employee stock purchase plan, percentage of market price, purchase date | 85.00% | ' | ' |
Employee stock purchase, discount from market price, purchase date | 15.00% | ' | ' |
Stock Options [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Share-based compensation, vesting period | '10 years | ' | ' |
Salaries, Wages and Officers' Compensation [Abstract] | ' | ' | ' |
Compensation expense, all share-based payment plans | 234 | 166 | 269 |
Employee Stock Purchase Plan [Abstract] | ' | ' | ' |
Stock options, awarded, outstanding | 662,246 | ' | ' |
Stock Appreciation Rights (SARs) [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Deferred compensation agreement with individual, annual grant per nonemployee director | 3,000 | ' | ' |
Share-based compensation, vesting period | '5 years | ' | ' |
Salaries, Wages and Officers' Compensation [Abstract] | ' | ' | ' |
Compensation expense, all share-based payment plans | 315 | 283 | 185 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Unvested, beginning balance | 257,817 | ' | ' |
Granted | 117,280 | ' | ' |
Forfeited | 0 | ' | ' |
Vested | -91,644 | ' | ' |
Unvested, ending balance | 283,453 | 257,817 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Unvested, weighted average award date value, beginning balance | $3.17 | ' | ' |
Granted, weighted average award date value | $3.17 | ' | ' |
Forfeited, weighted average award date value | $0 | ' | ' |
Vested, weighted average award date value | $3.23 | ' | ' |
Unvested, weighted average award date value, ending balance | $3.15 | $3.17 | ' |
Weighted average remaining contractual life (years) | '2 years 2 months 12 days | ' | ' |
Unrecognized compensation cost | 630 | ' | ' |
Aggregate intrinsic value | 6,775 | ' | ' |
Employee SSARs [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Unvested, ending balance | 253,720 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Unvested, weighted average award date value, ending balance | $3.24 | ' | ' |
Weighted average remaining contractual life (years) | '2 years 1 month 6 days | ' | ' |
Unrecognized compensation cost | 575 | ' | ' |
Aggregate intrinsic value | 6,064 | ' | ' |
Nonemployee Director SSARs [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Unvested, ending balance | 29,733 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Unvested, weighted average award date value, ending balance | $2.32 | ' | ' |
Weighted average remaining contractual life (years) | '2 years 6 months | ' | ' |
Unrecognized compensation cost | 55 | ' | ' |
Aggregate intrinsic value | 711 | ' | ' |
Restricted Stock Units (RSUs) [Member] | ' | ' | ' |
Salaries, Wages and Officers' Compensation [Abstract] | ' | ' | ' |
Compensation expense, all share-based payment plans | 445 | 644 | 485 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Unvested, beginning balance | 78,653 | ' | ' |
Granted | 42,290 | ' | ' |
Forfeited | 0 | ' | ' |
Vested | -25,385 | ' | ' |
Unvested, ending balance | 95,558 | 78,653 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Unvested, weighted average award date value, beginning balance | $16.87 | ' | ' |
Granted, weighted average award date value | $21.67 | ' | ' |
Forfeited, weighted average award date value | $0 | ' | ' |
Vested, weighted average award date value | $16.73 | ' | ' |
Unvested, weighted average award date value, ending balance | $19.03 | $16.87 | ' |
Weighted average remaining contractual life (years) | '2 years 9 months 18 days | ' | ' |
Unrecognized compensation cost | 1,098 | ' | ' |
Aggregate intrinsic value | 2,284 | ' | ' |
Employee PRSUs [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Unvested, ending balance | 86,252 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Unvested, weighted average award date value, ending balance | $18.69 | ' | ' |
Weighted average remaining contractual life (years) | '2 years 10 months 24 days | ' | ' |
Unrecognized compensation cost | 932 | ' | ' |
Aggregate intrinsic value | 2,062 | ' | ' |
Nonemployee Director PRSUs [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Unvested, ending balance | 9,306 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Unvested, weighted average award date value, ending balance | $22.18 | ' | ' |
Weighted average remaining contractual life (years) | '2 years 3 months 18 days | ' | ' |
Unrecognized compensation cost | 166 | ' | ' |
Aggregate intrinsic value | $222 | ' | ' |
Employee Stock Option [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Share-based compensation, number of shares available for grant | 3,200,000 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Number outstanding | 656,912 | ' | ' |
Weighted average remaining contractual life (years) | '5 years 11 months 16 days | ' | ' |
Outstanding options, weighted average exercise price | $16.68 | ' | ' |
Number exercisable | 336,812 | ' | ' |
Exercisable options, weighted average exercise price | $12.96 | ' | ' |
Employee Stock Option [Member] | $11.25 [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Lower range limit | $11.25 | ' | ' |
Upper range limit | $11.25 | ' | ' |
Number outstanding | 220,791 | ' | ' |
Weighted average remaining contractual life (years) | '2 years 5 months 5 days | ' | ' |
Outstanding options, weighted average exercise price | $11.25 | ' | ' |
Number exercisable | 220,791 | ' | ' |
Exercisable options, weighted average exercise price | $11.25 | ' | ' |
Employee Stock Option [Member] | $16.00 [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Lower range limit | $16 | ' | ' |
Upper range limit | $16 | ' | ' |
Number outstanding | 128,221 | ' | ' |
Weighted average remaining contractual life (years) | '5 years 10 months 2 days | ' | ' |
Outstanding options, weighted average exercise price | $16 | ' | ' |
Number exercisable | 72,621 | ' | ' |
Exercisable options, weighted average exercise price | $16 | ' | ' |
Employee Stock Option [Member] | $16.60 [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Lower range limit | $16.60 | ' | ' |
Upper range limit | $16.60 | ' | ' |
Number outstanding | 109,400 | ' | ' |
Weighted average remaining contractual life (years) | '6 years 10 months 2 days | ' | ' |
Outstanding options, weighted average exercise price | $16.60 | ' | ' |
Number exercisable | 43,400 | ' | ' |
Exercisable options, weighted average exercise price | $16.60 | ' | ' |
Employee Stock Option [Member] | $23.20 [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Lower range limit | $23.20 | ' | ' |
Upper range limit | $23.20 | ' | ' |
Number outstanding | 198,500 | ' | ' |
Weighted average remaining contractual life (years) | '9 years 5 months 23 days | ' | ' |
Outstanding options, weighted average exercise price | $23.20 | ' | ' |
Number exercisable | 0 | ' | ' |
Exercisable options, weighted average exercise price | $23.20 | ' | ' |
Director Stock Option [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Deferred compensation aggrangement with individual, nonemployee director, former plan, term | 'six | ' | ' |
Deferred compensation arrangement with individual, nonemployee director, annual grant per director, former plan | 4,000 | ' | ' |
Director Stock Option [Member] | $ 16.40 [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Lower range limit | $16.40 | ' | ' |
Upper range limit | $16.40 | ' | ' |
Number outstanding | 5,334 | ' | ' |
Weighted average remaining contractual life (years) | '8 months 16 days | ' | ' |
Outstanding options, weighted average exercise price | $16.40 | ' | ' |
Number exercisable | 5,334 | ' | ' |
Exercisable options, weighted average exercise price | $16.40 | ' | ' |